Stockreport

HemaCare and Charles River Laboratories Partner to Provide Human-Derived Biological Material to China

HEMACARE CORP  (HEMA) 
NASDAQ:AMEX Investor Relations: hemacare.com/investors
PDF New distribution partnership allows high-quality human primary cells to reach the Chinese market LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation (OTCMKTS: HEMA), a [Read more]